Internet-based Cognitive Behavioural Therapy (iCBT) for Perinatal Anxiety and Depression Versus Treatment As Usual: Study Protocol for Two Randomised Controlled Trials
Overview
Pharmacology
Authors
Affiliations
Background: We aimed to evaluate the acceptability and efficacy of two brief, Internet-delivered cognitive behavioural therapy interventions-MUMentum Pregnancy (study 1) and MUMentum Postnatal (study 2)-in reducing maternal symptoms of anxiety, depression and overall psychological distress compared to usual care in the perinatal period.
Methods/design: Women who are pregnant (study 1) or < 12 months postpartum (study 2) with current clinically elevated symptoms of anxiety and/or depression according to validated self-report measures, will be recruited via the research arm of a not-for-profit clinical and research unit in Australia and randomised to the intervention group or treatment as usual control group. The minimum sample size for each study (alpha 0.05; power 0.80 for a g of 0.80) was identified as 50 with at least 10% more to be recruited to account for expected attrition. The co-primary outcome measures are the Patient Health Questionnaire 9-item scale and Generalised Anxiety Disorder 7-item scale to measure depression and anxiety symptom severity, respectively, and will be administered at the following primary time-points: baseline; post treatment; and at one-month follow-up. Psychological distress will be measured according to the Kessler-10 psychological distress scale at each primary time-point and will also be completed before each lesson for those in the intervention group. The total trial period nine weeks for study 1 and 11 weeks for study 2. Program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at one-month follow-up.
Discussion: The current randomised controlled trial seeks to extend the literature by evaluating the efficacy of a self-help intervention for women in the perinatal period. If efficacious, the MUMentum programs have the potential to be easily disseminated via https://thiswayup.org.au/ to large numbers of women across Australia as an intervention for women screening positive for anxiety, depressive or distress symptoms during pregnancy or postpartum.
Trial Registration: Australian New Zealand Clinical Trials Registry, ACTRN12616000560493 ; ACTRN12616000559415 . Registered on 2nd May 2016.
Roberge P, Vasiliadis H, Chapdelaine A, Battista M, Beaulieu M, Chomienne M BMC Psychiatry. 2025; 25(1):237.
PMID: 40075340 PMC: 11905520. DOI: 10.1186/s12888-025-06636-3.
Abdelaziz E, Alshammari A, Elsharkawy N, Oraby F, Ramadan O BMC Pregnancy Childbirth. 2025; 25(1):233.
PMID: 40033245 PMC: 11877725. DOI: 10.1186/s12884-025-07341-5.
Kaur Kang H, Bisht B, Kaur M, Alexis O, Worsley A, John D Campbell Syst Rev. 2024; 20(2):e1399.
PMID: 38645302 PMC: 11032640. DOI: 10.1002/cl2.1399.
Technology-Based Approaches for Supporting Perinatal Mental Health.
Novick A, Kwitowski M, Dempsey J, Cooke D, Dempsey A Curr Psychiatry Rep. 2022; 24(9):419-429.
PMID: 35870062 PMC: 9307714. DOI: 10.1007/s11920-022-01349-w.
Beerli J, Ehlert U, Amiel Castro R BMC Prim Care. 2022; 23(1):172.
PMID: 35836110 PMC: 9281123. DOI: 10.1186/s12875-022-01779-8.